Conditional reprogrammed human limbal epithelial cell model for anti-SARS-CoV-2 drug screening

Yu Xiao1,2, Ling Wang3, Shi-Xu Li3

  • 1Shenzhen Research Institute, Wuhan University, Shenzhen 518057, Guangdong Province, China.

Heliyon
|May 3, 2024
PubMed

Insights

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects ocular limbal epithelial cells, leading to conjunctivitis. This discovery establishes a new cell model for screening antiviral drugs against COVID-19.

Area of Science:

  • Ophthalmology
  • Virology
  • Cell Biology

Background:

  • Understanding SARS-CoV-2 transmission is crucial for controlling the COVID-19 pandemic.
  • The ocular surface's role in SARS-CoV-2 infection requires further investigation.
  • Identifying effective antiviral therapies remains a global health priority.

Purpose of the Study:

  • To investigate SARS-CoV-2 infection of ocular surface epithelial cells.
  • To establish a novel cell model for studying ocular viral infections.
  • To screen for potential antiviral drugs using the developed ocular cell model.

Main Methods:

  • Infection of ocular surface limbal epithelial cells with SARS-CoV-2.
  • Analysis of viral entry and replication mechanisms, including receptor dependence (ACE2, TMPRSS2).
  • Screening of natural product libraries for antiviral activity against SARS-CoV-2 in the ocular model.

Main Results:

  • SARS-CoV-2 specifically infects ocular surface limbal epithelial cells, not other ocular regions.
  • Viral entry and replication are dependent on ACE2, TMPRSS2, and other receptors.
  • Infection induced mild cytopathic effects (CPE) and interleukin-6 (IL-6) secretion, correlating with conjunctivitis symptoms.
  • Two natural product libraries yielded several previously unreported antiviral compounds.
  • Established an effective cell model for drug screening and mechanistic studies of ocular SARS-CoV-2 infection.

Conclusions:

  • The ocular surface limbal epithelium is a susceptible site for SARS-CoV-2 infection.
  • The developed limbal cell model is suitable for studying COVID-19 ocular manifestations and for antiviral drug discovery.
  • Findings highlight commonalities between systemic COVID-19 and ocular SARS-CoV-2 infections, aiding therapeutic development.

Related Concept Videos